Home » Market News » DirectorsTalk Highlights » CBD Oil for Alzheimer’s & Dementia
Sativa Group

CBD Oil for Alzheimer’s & Dementia

Hemp and CBD oil were federally legalized with the 2018 Farm Bill, but scientists have been researching cannabidiol and its potential benefits for many years prior to the cannabis boom.

CBD products are gaining popularity at a rapid pace, mainly due to the number of conditions potentially alleviated by this compound.

Researchers are discovering new symptoms that CBD may be able to treat or help with in some way — from anxiety to inflammation and neurodegenerative diseases like dementia. CBD may provide relief to thousands of people across the country.

Sativa Group Plc (NEX:SATI) is the UK’s leading quoted CBD Wellness and medicinal cannabis group with five operating subsidiaries. Goodbody Botanicals provides CBD products online and to retail markets including pharmacies, wellness stores and grocers. Goodbody Wellness is a high-street retail brand with dedicated CBD Wellness stores providing a premium shopping experience to consumers. Tessellate Collective is a direct-selling network marketing platform servicing consumers at home. Phytovista laboratories provides independent testing of CBD products to both external customers and fellow Group businesses. Sativa Grow holds a Controlled Drug licence and cultivates cannabis plants to fulfill its partnership agreement with King’s College London to research the impact of cannabinoids on inflammation and respiratory conditions.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.